Joji Nakayama
Direktor/Vorstandsmitglied bei AJINOMOTO CO., INC.
Profil
Joji Nakayama is an Independent Outside Director at Ajinomoto Co., Inc. since 2021.
Previously, he was the Chairman at Daiichi Sankyo Co., Ltd.
from 2019 to 2020.
He also worked as a Director at Daiichi Pharmaceutical Co., Ltd.
Mr. Nakayama holds a graduate degree from Osaka University and an MBA from Northwestern University.
Aktive Positionen von Joji Nakayama
| Unternehmen | Position | Beginn |
|---|---|---|
| AJINOMOTO CO., INC. | Direktor/Vorstandsmitglied | 01.06.2021 |
Ehemalige bekannte Positionen von Joji Nakayama
| Unternehmen | Position | Ende |
|---|---|---|
| DAIICHI SANKYO CO., LTD. | Vorstandsvorsitzender | 01.06.2019 |
Daiichi Pharmaceutical Co., Ltd.
 Daiichi Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Daiichi Pharmaceutical Co. Ltd. manufactured pharmaceutical products. It used to make prescription drugs, OTC treatments and animal health products. The firm's prescription drugs included treatments for allergies, hypertension and stroke; it also has drugs in clinical trials. It was founded in 1915 and was located in Tokyo, Japan. | Direktor/Vorstandsmitglied | - |
Ausbildung von Joji Nakayama
| Northwestern University | Masters Business Admin |
| Osaka University | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| DAIICHI SANKYO CO., LTD. | Health Technology |
| AJINOMOTO CO., INC. | Consumer Non-Durables |
| Private Unternehmen | 1 |
|---|---|
Daiichi Pharmaceutical Co., Ltd.
Daiichi Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Daiichi Pharmaceutical Co. Ltd. manufactured pharmaceutical products. It used to make prescription drugs, OTC treatments and animal health products. The firm's prescription drugs included treatments for allergies, hypertension and stroke; it also has drugs in clinical trials. It was founded in 1915 and was located in Tokyo, Japan. | Health Technology |
